Aprea Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $1 | $118 | $162 | $205 |
Gross Profit | -3 | -1,794 | -2,320 | -2,153 |
EBITDA | -2,966 | -3,382 | -4,080 | -3,220 |
EBIT | -2,972 | -3,387 | -4,085 | -3,226 |
Net Income | -2,972 | -3,238 | -3,932 | -2,894 |
Net Change In Cash | 1 | 118 | 162 | 205 |
Free Cash Flow | -3,263 | -3,130 | -3,631 | -3,510 |
Cash | 13,718 | 16,532 | 19,275 | 22,849 |
Basic Shares | 6,372 | 6,083 | 5,993 | 5,954 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $1,502 | $583 | $0 | $0 |
Gross Profit | -7,860 | 576 | -16,402 | -271 |
EBITDA | -14,297 | -14,279 | -37,367 | -36,855 |
EBIT | -14,319 | -14,286 | -37,372 | -37,127 |
Net Income | -12,958 | -14,286 | -112,662 | -36,536 |
Net Change In Cash | 1,502 | 583 | 0 | 0 |
Free Cash Flow | -13,572 | -12,270 | -25,011 | -37,686 |
Cash | 22,849 | 21,606 | 28,786 | 53,076 |
Basic Shares | 5,509 | 3,617 | 82 | 1,064 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.47 |
2025-06-30 | -$0.53 |
2025-03-31 | -$0.65 |
2024-12-31 | -$0.49 |
